Market Overview - On August 20, the medical services sector rose by 0.33% compared to the previous trading day, with Haocen Medical leading the gains [1] - The Shanghai Composite Index closed at 3766.21, up 1.04%, while the Shenzhen Component Index closed at 11926.74, up 0.89% [1] Top Gainers in Medical Services - Haocen Medical (002622) closed at 3.96, up 10.00% with a trading volume of 827,000 shares and a transaction value of 322 million yuan [1] - Meinian Health (002044) closed at 5.87, up 4.45% with a trading volume of 2,284,200 shares and a transaction value of 1.323 billion yuan [1] - Baicheng Pharmaceutical (301096) closed at 56.47, up 3.31% with a trading volume of 72,900 shares and a transaction value of 401 million yuan [1] Top Losers in Medical Services - Innovation Medical (002173) closed at 23.05, down 7.21% with a trading volume of 1,255,900 shares and a transaction value of 2.968 billion yuan [2] - Boji Pharmaceutical (300404) closed at 12.36, down 6.01% with a trading volume of 819,000 shares and a transaction value of 1.015 billion yuan [2] - Nanmo Biological (688265) closed at 61.50, down 5.38% with a trading volume of 32,800 shares and a transaction value of 201 million yuan [2] Capital Flow Analysis - The medical services sector experienced a net outflow of 2.075 billion yuan from institutional investors, while retail investors saw a net inflow of 1.893 billion yuan [2][3] - The top net inflow from retail investors was in Meinian Health (002044) with 201 million yuan, despite a net outflow from institutional investors [3] - Haocen Medical (002622) had a net inflow of 114 million yuan from institutional investors, but also faced significant outflows from retail investors [3]

天眼查商业履历信息显示，皓宸医疗科技股份有限公司，成立于1998年，位于吉林市，是一家以从事卫 生为主的企业。企业注册资本84000万人民币，实缴资本11198.74万人民币。公司法定代表人为陆璐。 金融界消息 截至2025年8月20日收盘，皓宸医疗（002622）报收于3.96元，上涨10.0%，换手率9.85%， 成交量82.70万手，成交金额3.22亿元。 资金流向方面，今日主力资金净流入1.14亿元，占比成交额35.55%。其中，超大单净流入1.30亿元、占 成交额40.47%，大单净流出1583.43万元、占成交额4.92%，中单净流出流出4474.20万元、占成交额 13.91%，小单净流出6958.23万元、占成交额21.64%。 皓宸医疗最新一期业绩显示，截至2025一季报，公司营业总收入1.43亿元、同比减少12.58%，归属净利 润1221.46万元，同比减少167.13%，扣非净利润1254.62万元，同比减少166.97%，流动比率0.311、速动 比率0.254、资产负债率71.09%。 通过天眼查大数据分析，皓宸医疗科技股份有限公司共对外投资了13家企业，参与招投标项目42次，知 ...

Core Viewpoint - The stock price of Haocen Medical has experienced a decline, closing at 3.60 yuan, down 3.74% from the previous trading day, indicating volatility in the market [1] Group 1: Stock Performance - As of August 19, 2025, at 15:00, Haocen Medical's stock price was reported at 3.60 yuan, a decrease of 3.74% from the previous trading day [1] - The opening price for the day was 3.68 yuan, with a high of 3.74 yuan and a low of 3.56 yuan [1] - The trading volume reached 805,400 hands, with a total transaction amount of 291 million yuan [1] - A rapid rebound occurred at 9:45 AM, with a price increase of over 2% within 5 minutes, reaching 3.65 yuan and a transaction amount of 85.46 million yuan during that period [1] - The net outflow of main funds for the day was 13.51 million yuan, while the cumulative net inflow over the past five trading days was 54.27 million yuan [1] Group 2: Company Overview - Haocen Medical's main business includes medical services and medical beauty, with its registered location in Jilin Province [1] - The company is also involved in smart grid and other business directions [1]

Group 1 - The core viewpoint of the news is that Haocen Medical experienced a significant stock price increase, reaching a limit up of 9.94% on August 14, with a trading price of 3.87 yuan per share and a total market capitalization of 3.251 billion yuan [1] - Haocen Medical is primarily engaged in oral medical services and industrial manufacturing, with a focus on the research and innovation of permanent magnet switch products [1] - The company was listed on the Shenzhen Stock Exchange in 2011 under the stock code 002622 and acquired a controlling stake in Guangdong Delun Medical Group Co., Ltd. in 2021 [1] Group 2 - As of March 31, Haocen Medical had 54,000 shareholders, with an average of 15,500 circulating shares per shareholder [2] - For the first quarter of 2025, Haocen Medical reported an operating income of 143 million yuan, a year-on-year decrease of 12.58%, and a net profit attributable to shareholders of -12.2146 million yuan, a year-on-year decrease of 167.13% [2]

风险提示：股市有风险，投资需谨慎。 来源：金融界 截至2025年8月13日收盘，皓宸医疗报3.52元，较前一交易日下跌1.12%。当日股价波动剧烈，最高触及 3.80元，最低下探3.35元，振幅达12.64%。全天成交194.78万手，成交金额6.90亿元。 8月13日盘中，皓宸医疗出现快速波动。早盘9点35分出现快速反弹，5分钟内涨幅超过2%；随后在10点 29分又出现快速回调，5分钟内跌幅超过2%。 资金流向方面，8月13日主力资金净流出204.57万元，占流通市值的0.07%。近五个交易日主力资金累计 净流入1.96亿元，占流通市值的6.63%。 皓宸医疗主营业务涵盖医疗服务和医疗美容领域。公司注册地位于吉林省，是一家专注于医疗健康产业 的企业。 ...

Market Performance - On August 13, the medical services sector rose by 4.02%, led by Innovative Medical [1] - The Shanghai Composite Index closed at 3683.46, up 0.48%, while the Shenzhen Component Index closed at 11551.36, up 1.76% [1] Individual Stock Performance - The table lists various stocks in the medical services sector, with notable declines including *ST Bio down 4.95% and ST Zhongzhu down 2.66% [1] - Other stocks such as Lanwei Medical and Baicheng Pharmaceutical also experienced minor declines of 1.76% and 1.59% respectively [1] Capital Flow Analysis - The medical services sector saw a net inflow of 1.962 billion yuan from institutional investors, while retail investors experienced a net outflow of 1.888 billion yuan [3] - Notable stocks with significant net inflows from institutional investors include Yaoming Kande with 1.13 billion yuan and Kanglong Huacheng with 248 million yuan [3] - Conversely, retail investors showed significant outflows from stocks like Yaoming Kande and Kanglong Huacheng, indicating a shift in investor sentiment [3]

风险提示：股市有风险，投资需谨慎。 来源:金融界 截至2025年8月12日15时，皓宸医疗股价报3.56元，较前一交易日上涨0.32元。当日开盘价为3.27元，最 高触及3.56元，最低下探3.25元，成交量为934562手，成交金额达3.24亿元。 皓宸医疗主营业务涵盖医疗服务领域，涉及医疗美容、智能电网等多个细分行业。公司总市值29.90亿 元，流通市值与总市值相同。 8月12日早盘交易时段，皓宸医疗曾出现快速回调走势，在五分钟内跌幅超过2%，当时成交额达到1.35 亿元。当日主力资金净流入11229.96万元，近五个交易日累计净流入19420.04万元。 ...

资金面上看，今日牙科医疗概念板块获主力资金净流出4.75亿元，其中，8股获主力资金净流入，净流 入资金居首的是皓宸医疗，今日主力资金净流入1.12亿元，净流入资金居前的还有美年健康、奕瑞科 技、宏盛股份等，主力资金分别净流入4540.95万元、4527.53万元、2863.59万元。 资金流入比率方面，皓宸医疗、美年健康、宏盛股份等流入比率居前，主力资金净流入率分别为 34.57%、11.58%、11.22%。（数据宝） 牙科医疗概念资金流入榜 | 代码 | 简称 | 今日涨跌幅 | 今日换手率 | 主力资金流量（万 | 主力资金净流入比率 | | --- | --- | --- | --- | --- | --- | | | | （%） | （%） | 元） | （%） | | 002622 | 皓宸医 疗 | 9.88 | 11.13 | 11196.57 | 34.57 | | 002044 | 美年健 康 | 0.19 | 1.92 | 4540.95 | 11.58 | | 688301 | 奕瑞科 技 | 4.81 | 2.37 | 4527.53 | 10.01 | | 603090 | 宏盛股 ...

| 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 300683 | 海特生物 | 50.48 | -8.67% | 15.85万 | 8.11亿 | | 000504 | *ST生物 | 11.91 | -5.02% | 3.61万 | 4301.65万 | | 688710 | 益诺思 | 42.19 | -3.01% | 1.48万 | 6274.17万 | | 688222 | 成都先导 | 22.28 | -2.88% | 1 20.73万 | 4.60亿 | | 301509 | 金凯生松 | 38.46 | -2.83% | 5.59万 | 2.15亿 | | 688238 | 和元生物 | 7.61 | -2.56% | 13.40万 | 1.02亿 | | 301201 | 诚达药业 | 28.83 | -2.47% | 5.98万 | 1.73亿 | | 300149 | 香督医药 | 12.63 | -2.40% | 36.15万 | 4.58亿 | | 688621 | 阳光 ...

Group 1 - The stock of Haocen Medical reached a closing price of 3.56 yuan on August 12, with a limit-up performance and a closing order fund of 89.68 million yuan, accounting for 3.0% of its market capitalization [1] - The growth in the oral medical business is significant, with Delun Medical's sales revenue expected to increase by 13.94% year-on-year in 2024, indicating a strong expansion trend [1] - The company has improved its operational efficiency, with net profit losses narrowing by 60.06% year-on-year in 2024, signaling positive developments [1] Group 2 - Research and development expenses are projected to surge by 163% year-on-year in Q1 2025, reinforcing the company's strategic investments to enhance long-term competitiveness [1] - A new outpatient clinic in Zhaoqing is set to open in May 2025, along with the expansion of several medical facilities, increasing the number of dental chairs by over 100, thereby enhancing service capacity [1] - The company secured a 113.2 million yuan working capital loan, alleviating short-term financial pressures [1]